Search

Start Over Creator Srbová, Martina

2. Simvastatin and dehydroepiandrosterone sulfate effects against hypoxic pulmonary hypertension are not additive

Creator:
Krása, Kryštof, Vajnerová, Olga, Ďurišová, Jana, Minaříková, Marcela, Miková, Dana, Srbová, Martina, Chalupský, Karel, Kaftanová, Barbora, and Hampl, Václav
Format:
počítač and online zdroj
Type:
model:article and TEXT
Subject:
statin, dehydroepiandrosterone, pulmonary hypertension, and rats
Language:
English
Description:
Pulmonary hypertension is a group of disorders characterized by elevated mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance. To test our hypothesis that combining two drugs useful in experimental pulmonary hypertension, statins and dehydroepiandrosterone sulfate (DHEA-S), is more effective than either agent alone, we induced pulmonary hypertension in adult male rats by exposing them to hypoxia (10 %O2) for 3 weeks. We treated them with simvastatin (60 mg/l) and DHEA-S (100 mg/l) in drinking water, either alone or in combination. Both simvastatin and DHEA-S reduced mPAP (froma mean±s.d. of 34.4±4.4 to 27.6±5.9 and 26.7±4.8 mmHg, respectively), yet their combination was not more effective (26.7±7.9 mmHg). Differences in the degree of oxidative stress (indicated by malondialdehydeplasma concentration), the rate of superoxide production (electron paramagnetic resonance), or blood nitric oxide levels (chemiluminescence) did not explain the lack of additivity of the effect of DHEA-S and simvastatin on pulmonary hypertension. We propose that the main mechanism of both drugs on pulmonary hypertension could be their inhibitory effect on 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, which could explain their lack of additivity.
Rights:
http://creativecommons.org/licenses/by-nc-sa/4.0/ and policy:public